Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
5,631.00
-32.00 (-0.57%)
Mar 13, 2025, 3:30 PM JST
Kobayashi Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Market Capitalization | 419,717 | 463,131 | 503,841 | 650,295 | 704,427 | 985,637 | Upgrade
|
Market Cap Growth | -8.08% | -8.08% | -22.52% | -7.68% | -28.53% | 36.03% | Upgrade
|
Enterprise Value | 354,822 | 412,429 | 409,238 | 545,580 | 602,944 | 888,822 | Upgrade
|
Last Close Price | 5646.00 | 6230.00 | 6673.81 | 8752.31 | 8673.05 | 11991.09 | Upgrade
|
PE Ratio | 41.69 | 46.00 | 24.77 | 32.48 | 35.73 | 51.32 | Upgrade
|
Forward PE | 28.07 | 30.11 | 24.52 | 33.46 | 34.40 | 48.90 | Upgrade
|
PS Ratio | 2.53 | 2.80 | 2.90 | 3.91 | 4.54 | 6.55 | Upgrade
|
PB Ratio | 1.97 | 2.17 | 2.46 | 3.29 | 3.60 | 5.40 | Upgrade
|
P/TBV Ratio | 2.40 | 2.40 | 2.75 | 3.52 | 3.85 | 5.81 | Upgrade
|
P/FCF Ratio | - | - | 89.91 | 37.88 | 37.56 | 48.82 | Upgrade
|
P/OCF Ratio | 41.18 | 41.18 | 27.44 | 20.38 | 31.42 | 41.09 | Upgrade
|
PEG Ratio | 2.38 | - | 20.43 | 13.38 | 7.89 | 7.89 | Upgrade
|
EV/Sales Ratio | 2.14 | 2.49 | 2.36 | 3.28 | 3.88 | 5.91 | Upgrade
|
EV/EBITDA Ratio | 10.84 | 12.60 | 12.92 | 17.12 | 19.58 | 29.71 | Upgrade
|
EV/EBIT Ratio | 14.36 | 16.69 | 15.97 | 20.58 | 23.23 | 34.44 | Upgrade
|
EV/FCF Ratio | -23.96 | - | 73.03 | 31.78 | 32.15 | 44.02 | Upgrade
|
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
Debt / FCF Ratio | - | - | 0.18 | 0.05 | 0.03 | 0.03 | Upgrade
|
Asset Turnover | 0.62 | 0.62 | 0.66 | 0.65 | 0.63 | 0.64 | Upgrade
|
Inventory Turnover | 3.37 | 3.37 | 3.88 | 4.51 | 4.55 | 4.47 | Upgrade
|
Quick Ratio | 2.48 | 2.48 | 2.37 | 2.94 | 3.24 | 2.94 | Upgrade
|
Current Ratio | 3.11 | 3.11 | 2.82 | 3.34 | 3.59 | 3.28 | Upgrade
|
Return on Equity (ROE) | 4.82% | 4.82% | 10.10% | 10.18% | 10.43% | 10.81% | Upgrade
|
Return on Assets (ROA) | 5.80% | 5.80% | 6.12% | 6.52% | 6.61% | 6.84% | Upgrade
|
Return on Capital (ROIC) | 7.35% | 7.35% | 7.92% | 8.39% | 8.55% | 9.04% | Upgrade
|
Return on Capital Employed (ROCE) | 11.29% | 11.29% | 12.12% | 12.99% | 12.86% | 13.71% | Upgrade
|
Earnings Yield | 2.40% | 2.17% | 4.04% | 3.08% | 2.80% | 1.95% | Upgrade
|
FCF Yield | -3.53% | -3.20% | 1.11% | 2.64% | 2.66% | 2.05% | Upgrade
|
Dividend Yield | 1.85% | 1.64% | 1.51% | 1.03% | 0.96% | 0.64% | Upgrade
|
Payout Ratio | 74.55% | 74.55% | 35.51% | 32.51% | 31.71% | 30.12% | Upgrade
|
Buyback Yield / Dilution | 1.98% | 1.98% | 1.67% | 1.27% | 0.05% | 0.32% | Upgrade
|
Total Shareholder Return | 3.83% | 3.62% | 3.19% | 2.30% | 1.01% | 0.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.